Vera Balz

1.1k total citations
38 papers, 838 citations indexed

About

Vera Balz is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Vera Balz has authored 38 papers receiving a total of 838 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Oncology and 10 papers in Immunology. Recurrent topics in Vera Balz's work include Cancer-related Molecular Pathways (12 papers), Immune Cell Function and Interaction (8 papers) and Immunotherapy and Immune Responses (7 papers). Vera Balz is often cited by papers focused on Cancer-related Molecular Pathways (12 papers), Immune Cell Function and Interaction (8 papers) and Immunotherapy and Immune Responses (7 papers). Vera Balz collaborates with scholars based in Germany, United States and Finland. Vera Balz's co-authors include H. Bier, Kathrin Scheckenbach, Thomas K. Hoffmann, Ulrike Bockmühl, Karl Götte, Murat Baş, Iver Petersen, Theresa L. Whiteside, U Friebe-Hoffmann and U. Häuser and has published in prestigious journals such as Neurology, Journal of Allergy and Clinical Immunology and International Journal of Cancer.

In The Last Decade

Vera Balz

38 papers receiving 818 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vera Balz Germany 17 364 331 192 172 145 38 838
N. de Vries Netherlands 16 442 1.2× 213 0.6× 247 1.3× 271 1.6× 100 0.7× 23 848
Bin Qiao China 18 353 1.0× 408 1.2× 125 0.7× 44 0.3× 188 1.3× 36 874
Tim N. Beck United States 14 298 0.8× 352 1.1× 99 0.5× 49 0.3× 151 1.0× 28 756
Yu-Juen Cheng Taiwan 10 331 0.9× 711 2.1× 167 0.9× 137 0.8× 530 3.7× 13 1.2k
Huimin Tian China 18 448 1.2× 313 0.9× 360 1.9× 53 0.3× 143 1.0× 34 1.0k
Sofia Spyridonidou Greece 15 232 0.6× 298 0.9× 80 0.4× 83 0.5× 211 1.5× 31 663
Xianlu Zhuo China 17 288 0.8× 496 1.5× 65 0.3× 82 0.5× 210 1.4× 69 841
Wenhua Lang United States 17 374 1.0× 784 2.4× 124 0.6× 184 1.1× 257 1.8× 28 1.3k
Fuxiang Zhou China 20 454 1.2× 540 1.6× 136 0.7× 52 0.3× 275 1.9× 85 1.2k
Ik‐Chan Song South Korea 17 208 0.6× 236 0.7× 139 0.7× 34 0.2× 89 0.6× 87 720

Countries citing papers authored by Vera Balz

Since Specialization
Citations

This map shows the geographic impact of Vera Balz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vera Balz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vera Balz more than expected).

Fields of papers citing papers by Vera Balz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vera Balz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vera Balz. The network helps show where Vera Balz may publish in the future.

Co-authorship network of co-authors of Vera Balz

This figure shows the co-authorship network connecting the top 25 collaborators of Vera Balz. A scholar is included among the top collaborators of Vera Balz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vera Balz. Vera Balz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Loeffler‐Wirth, Henry, et al.. (2022). Immunogenetic Predisposition to SARS-CoV-2 Infection. Biology. 12(1). 37–37. 8 indexed citations
2.
Enczmann, Jürgen, Vera Balz, Sebastian Kummer, et al.. (2022). Interleukin-7 and soluble Interleukin-7 receptor levels in type 1 diabetes – Impact of IL7RA polymorphisms, HLA risk genotypes and clinical features. Clinical Immunology. 235. 108928–108928. 5 indexed citations
3.
4.
Wiek, Constanze, Vera Balz, Vera Okpanyi, et al.. (2018). Mutational and Functional Analysis of FANCB as a Candidate Gene for Sporadic Head and Neck Squamous Cell Carcinomas. Anticancer Research. 38(3). 1317–1325. 6 indexed citations
5.
Dao, Vu Thao-Vi, et al.. (2016). Nitric oxide up-regulates endothelial expression of angiotensin II type 2 receptors. Biochemical Pharmacology. 112. 24–36. 21 indexed citations
6.
Scheckenbach, Kathrin, Stephan Baldus, Vera Balz, et al.. (2013). RAD51C – A new human cancer susceptibility gene for sporadic squamous cell carcinoma of the head and neck (HNSCC). Oral Oncology. 50(3). 196–199. 23 indexed citations
7.
Dao, Vu Thao-Vi, et al.. (2010). Catalase activity prevents exercise-induced up-regulation of vasoprotective proteins in venous tissue. Journal of Cellular and Molecular Medicine. 15(11). 2326–2334. 17 indexed citations
8.
Scheckenbach, Kathrin, Thomas K. Hoffmann, Adam Chaker, et al.. (2010). The checkpointkinase 2 (CHK2) 1100delC germ line mutation is not associated with the development of squamous cell carcinoma of the head and neck (SCCHN). Journal of Negative Results in BioMedicine. 9(1). 10–10. 2 indexed citations
9.
Hoffmann, Thomas K., Enikö Sonkoly, Sven Brandau, et al.. (2009). A novel mechanism for anti‐EGFR antibody action involves chemokine‐mediated leukocyte infiltration. International Journal of Cancer. 124(11). 2589–2596. 51 indexed citations
10.
Baş, Murat, Thomas K. Hoffmann, Christos Bantis, et al.. (2009). Potential genetic risk factors in angiotensin‐converting enzyme‐inhibitor‐induced angio‐oedema. British Journal of Clinical Pharmacology. 69(2). 179–186. 19 indexed citations
11.
Hoffmann, Thomas K., Enikö Sonkoly, U. Häuser, et al.. (2008). Alterations in the p53 pathway and their association with radio- and chemosensitivity in head and neck squamous cell carcinoma. Oral Oncology. 44(12). 1100–1109. 50 indexed citations
12.
Sproll, Christoph, Thomas K. Hoffmann, Kathrin Scheckenbach, et al.. (2008). Is there a role for the Fas-/Fas-Ligand pathway in chemoresistance of human squamous cell carcinomas of the head and neck (SCCHN)?. Oral Oncology. 45(1). 69–84. 6 indexed citations
13.
Scheckenbach, Kathrin, Vera Balz, Martin Wagenmann, & Thomas K. Hoffmann. (2008). An intronic alteration of the fibroblast growth factor 10 gene causing ALSG-(aplasia of lacrimal and salivary glands) syndrome. BMC Medical Genetics. 9(1). 114–114. 11 indexed citations
14.
Oppermann, Marc, Vera Balz, Volker Adams, et al.. (2008). Pharmacological induction of vascular extracellular superoxide dismutase expression in vivo. Journal of Cellular and Molecular Medicine. 13(7). 1271–1278. 30 indexed citations
15.
Ito, Daisuke, Carmen Visús, Thomas K. Hoffmann, et al.. (2007). Immunological characterization of missense mutations occurring within cytotoxic T cell‐defined p53 epitopes in HLA‐A*0201+ squamous cell carcinomas of the head and neck. International Journal of Cancer. 120(12). 2618–2624. 27 indexed citations
16.
Hoffmann, Thomas K., Christian Arsov, Murat Baş, et al.. (2005). T cells specific for HPV16 E7 epitopes in patients with squamous cell carcinoma of the oropharynx. International Journal of Cancer. 118(8). 1984–1991. 72 indexed citations
17.
Hoffmann, Thomas K., D. Häfner, Vera Balz, et al.. (2002). Antitumor activity of protein kinase C inhibitors and cisplatin in human head and neck squamous cell carcinoma lines. Anti-Cancer Drugs. 13(1). 93–100. 40 indexed citations
18.
Häuser, U., Vera Balz, Thomas E. Carey, et al.. (2002). Reliable detection of p53 aberrations in squamous cell carcinomas of the head and neck requires transcript analysis of the entire coding region. Head & Neck. 24(9). 868–873. 43 indexed citations
19.
Balz, Vera, et al.. (2002). Analysis of BRCA1, TP53, and TSG101 germline mutations in German breast and/or ovarian cancer families. Cancer Genetics and Cytogenetics. 138(2). 120–127. 16 indexed citations
20.
Hoffmann, Thomas K., Hans Bojar, Jürgen Eckel, et al.. (2002). Effects of tamoxifen on human squamous cell carcinoma lines of the head and neck. Anti-Cancer Drugs. 13(5). 521–531. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N. de Vries Breakdown of academic impact, for papers by Bin Qiao Breakdown of academic impact, for papers by Tim N. Beck Breakdown of academic impact, for papers by Yu-Juen Cheng Breakdown of academic impact, for papers by Huimin Tian Breakdown of academic impact, for papers by Sofia Spyridonidou Breakdown of academic impact, for papers by Xianlu Zhuo Breakdown of academic impact, for papers by Wenhua Lang Breakdown of academic impact, for papers by Fuxiang Zhou Breakdown of academic impact, for papers by Ik‐Chan Song
Rankless by CCL
2026